Authorizing pharmacists to substitute biosimilar biological products for prescribed biological reference products only under specified circumstances; requiring pharmacists or their designees to give specified notices and record specified information if the pharmacist substitutes an interchangeable biosimilar biological product for a prescribed biological reference product; etc.
Bill File Type: Regular
Effective Date(s): October 1, 2013
( 12-101, 12-504, 12-504.1 )
Last Updated: 2/3/2020 2:28 PM